Analyst Research

Report Title Price
Provider: ValuEngine, Inc.
$49.00
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Newman Ferrara LLP Announces Securities Fraud Class Action Lawsuit Has Been Filed Against Abiomed Inc


Tuesday, 4 Dec 2012 03:13pm EST 

Newman Ferrara LLP announced that class action lawsuit has been filed in the United States District Court for the District of Massachusetts against Abiomed Inc ("Abiomed") and certain of its executive officers, alleging violations of federal securities laws. Investors who purchased Abiomed securities between August 5, 2011 and October 31, 2012 (the "Class Period") may apply with the Court to be appointed Lead Plaintiff no later than January 15, 2013. The Lead Plaintiff will direct the litigation on behalf of the other class members. The Court will select the Lead Plaintiff from among applicants claiming the largest investment losses. 

Company Quote

25.28
0.34 +1.36%
21 Jul 2014